Taltz 80 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FSBJK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,086
Award facts
- Contract value 100% obligated
- $3,086.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,086.38 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on July 23, 2025, with an ultimate completion date of July 24, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used primarily to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, making this procurement part of the Defense Health Agency's pharmaceutical supply chain supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. This prime contract vehicle enables comprehensive pharmaceutical support globally, allowing AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to military healthcare programs worldwide. The contractor's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of specialty pharmaceutical deliveries to the Defense Logistics Agency, positions it as a critical vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FSBJK?
SPE2DB25FSBJK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FSBJK worth?
The government has obligated $3,086 on SPE2DB25FSBJK.
Is contract SPE2DB25FSBJK an order under another contract?
Yes. SPE2DB25FSBJK is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSBJK competed?
The extent of competition for SPE2DB25FSBJK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award